NPI: 1992776041 · WATERTOWN, WI 53098 · Clinical Medical Laboratory · NPI assigned 01/27/2006
Authorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
| Authorized Official | TRAYLOR, JOHNETTA (AO) |
| Parent Organization | LIFEPOINT HEALTH INC |
| NPI Enumeration Date | 01/27/2006 |
Other providers sharing the same authorized official: TRAYLOR, JOHNETTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 42,966 | $979K |
| 2019 | 49,112 | $854K |
| 2020 | 48,329 | $866K |
| 2021 | 53,396 | $953K |
| 2022 | 52,233 | $879K |
| 2023 | 60,170 | $1.04M |
| 2024 | 41,998 | $740K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,747 | 12,319 | $842K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,068 | 8,668 | $486K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,506 | 3,217 | $477K |
| 80053 | Comprehensive metabolic panel | 16,297 | 12,449 | $346K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,357 | 3,752 | $268K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,731 | 3,294 | $239K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 15,941 | 4,105 | $193K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,553 | 1,332 | $158K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,195 | 3,690 | $149K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,237 | 1,850 | $143K |
| 81001 | 11,115 | 8,848 | $139K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,968 | 3,794 | $138K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,673 | 3,005 | $134K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,390 | 1,953 | $127K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,350 | 12,653 | $125K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19,649 | 13,677 | $121K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,441 | 2,174 | $105K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,079 | 1,800 | $104K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,509 | 878 | $97K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,263 | 1,126 | $92K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 9,470 | 2,731 | $88K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,279 | 1,048 | $88K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2,497 | 2,229 | $82K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,466 | 2,198 | $79K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,780 | 1,427 | $71K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,686 | 1,345 | $68K |
| 87081 | 2,697 | 2,334 | $68K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,053 | 921 | $62K |
| 86710 | 3,154 | 2,702 | $60K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,052 | 3,472 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,434 | 1,278 | $57K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 995 | 819 | $52K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,703 | 2,317 | $46K |
| 80061 | Lipid panel | 3,461 | 3,032 | $44K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,124 | 4,145 | $43K |
| 84484 | 5,233 | 3,669 | $43K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,133 | 1,033 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 466 | 391 | $36K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,409 | 1,250 | $36K |
| 81025 | 3,759 | 3,100 | $36K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,754 | 2,424 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,144 | 1,001 | $34K |
| 85027 | 4,225 | 3,385 | $32K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 560 | 457 | $30K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 825 | 751 | $29K |
| 84145 | 1,700 | 1,279 | $23K | |
| 83690 | 4,864 | 3,829 | $23K | |
| 82962 | 3,000 | 1,683 | $22K | |
| G0378 | Hospital observation service, per hour | 1,018 | 530 | $21K |
| 76801 | 314 | 254 | $19K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,607 | 1,435 | $18K |
| 83880 | 885 | 675 | $17K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 411 | 356 | $16K |
| 83735 | 4,088 | 2,952 | $16K | |
| 85610 | 3,483 | 2,476 | $15K | |
| 83605 | 2,369 | 1,791 | $14K | |
| 87480 | 617 | 566 | $13K | |
| 80305 | 1,131 | 986 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | 1,379 | 1,144 | $12K |
| 85380 | 1,591 | 1,294 | $11K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 625 | 552 | $11K |
| 87660 | 617 | 566 | $10K | |
| 87807 | 279 | 255 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 161 | 126 | $9K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 139 | 110 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 438 | 353 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 241 | 225 | $8K |
| 97162 | 326 | 237 | $8K | |
| 97161 | 789 | 578 | $7K | |
| 76830 | Ultrasound, transvaginal | 249 | 223 | $7K |
| 84703 | 844 | 717 | $7K | |
| 87510 | 617 | 566 | $7K | |
| 80179 | 423 | 355 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 496 | 433 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,235 | 6,082 | $6K |
| 74018 | 806 | 645 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 82 | 70 | $6K |
| 86803 | 441 | 390 | $6K | |
| 86703 | 445 | 395 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 957 | 758 | $6K |
| 86850 | 1,059 | 886 | $6K | |
| 86140 | 1,413 | 1,076 | $6K | |
| 86780 | 603 | 539 | $5K | |
| 87186 | 823 | 674 | $5K | |
| 82553 | 1,168 | 946 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 124 | 103 | $5K |
| 80143 | 477 | 403 | $5K | |
| 71045 | Radiologic examination, chest; single view | 6,774 | 5,316 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 152 | 60 | $4K |
| 84439 | 453 | 388 | $4K | |
| 86900 | 1,220 | 922 | $4K | |
| 87340 | 423 | 374 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 45 | 39 | $4K |
| 86901 | 1,333 | 1,028 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 133 | 115 | $3K |
| 87653 | 66 | 52 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,951 | 5,313 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,427 | 2,539 | $3K |
| 80050 | General health panel | 297 | 255 | $3K |
| 73630 | 582 | 485 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 75 | 65 | $2K |
| 82950 | 61 | 54 | $2K | |
| 12001 | 13 | 12 | $2K | |
| 86592 | 221 | 191 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,412 | 3,339 | $2K |
| 87077 | 277 | 238 | $1K | |
| 82803 | 76 | 51 | $1K | |
| 85652 | 581 | 451 | $1K | |
| 73610 | 500 | 424 | $1K | |
| 90837 | Psychotherapy, 53 minutes with patient | 629 | 387 | $1K |
| 72100 | 125 | 100 | $1K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 684 | 620 | $1K |
| 36415 | Collection of venous blood by venipuncture | 19,759 | 13,697 | $1K |
| 82043 | 109 | 97 | $966.73 | |
| 82565 | 120 | 91 | $943.75 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 16 | 13 | $943.73 |
| 87075 | 48 | 39 | $889.05 | |
| 87040 | 109 | 77 | $886.93 | |
| 85730 | 263 | 224 | $830.39 | |
| 84702 | 66 | 52 | $814.21 | |
| 82150 | 185 | 159 | $794.90 | |
| 85007 | 171 | 134 | $759.38 | |
| 73030 | 187 | 157 | $697.13 | |
| 86762 | 38 | 36 | $519.76 | |
| 82550 | 78 | 61 | $517.10 | |
| 82607 | 61 | 50 | $504.43 | |
| 82947 | 161 | 122 | $495.37 | |
| J2704 | Injection, propofol, 10 mg | 1,373 | 1,165 | $402.00 |
| 73110 | 66 | 48 | $392.15 | |
| 80320 | 614 | 509 | $371.94 | |
| 82728 | 13 | 12 | $365.69 | |
| 82330 | 40 | 26 | $274.62 | |
| 94761 | 4,257 | 3,445 | $214.61 | |
| 73562 | 75 | 69 | $212.73 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 387 | 346 | $209.77 |
| 0352U | 289 | 254 | $173.78 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,391 | 1,954 | $158.07 |
| 83550 | 25 | 24 | $157.71 | |
| 84132 | 108 | 80 | $153.16 | |
| 73130 | 100 | 76 | $145.41 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 31 | 25 | $134.31 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,753 | 2,421 | $99.48 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 12 | 12 | $86.03 |
| 36000 | 76 | 70 | $76.23 | |
| 73502 | 33 | 27 | $67.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,424 | 2,069 | $65.13 |
| 84295 | 21 | 15 | $34.89 | |
| 73090 | 20 | 13 | $33.76 | |
| 0353U | 146 | 122 | $21.36 | |
| 96376 | 649 | 467 | $13.90 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,745 | 3,058 | $8.81 |
| 94760 | 1,890 | 1,586 | $7.07 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,331 | 2,785 | $5.76 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,546 | 2,154 | $4.03 |
| 90686 | 69 | 56 | $2.50 | |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | 70 | 54 | $0.64 |
| A9270 | Non-covered item or service | 1,397 | 1,062 | $0.39 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 992 | 840 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 153 | 123 | $0.00 |
| 92134 | 68 | 54 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 30 | 24 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 145 | 123 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 72 | 67 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 96 | 70 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 13 | 12 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 13 | 12 | $0.00 |
| 94664 | 13 | 12 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 64 | 50 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,283 | 1,108 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,398 | 1,100 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 13 | 13 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,603 | 1,393 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 112 | 99 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 79 | 67 | $0.00 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | 238 | 200 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 61 | 60 | $0.00 |
| J3490 | Unclassified drugs | 34 | 27 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 32 | 27 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 51 | 29 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 32 | 27 | $0.00 |
| 90674 | 15 | 15 | $0.00 |